Nivalis Therapeutics
Latest round
- Series B
Last raised
- Jul 2010
Total raised
- $10M
Investors
- 3
About Nivalis Therapeutics
Nivalis Therapeutics, headquartered in Boulder, US, was founded in 2007 to specialize in innovative therapies for cystic fibrosis.Nivalis Therapeutics specializes in the development of disease-modifying therapies that target inflammatory lung diseases, particularly cystic fibrosis. Their primary offerings include proprietary small molecule inhibitors of GSNOR, aiming to enhance organ repair and regeneration by preserving intracellular GSNO levels.73 mn.55 mn from its IPO in June 2015 to accelerate the development of its innovative therapies for cystic fibrosis. The company aims to launch new products targeting additional inflammatory lung conditions in the coming years, expanding its reach into European markets by 2025.
Who invested in Nivalis Therapeutics
3 investors across 1 round
See all investors in Nivalis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 12, 2010
Amount
$10M
Investors
Questions about Nivalis Therapeutics
Who invested in Nivalis Therapeutics?
Nivalis Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nivalis Therapeutics raised?
Nivalis Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nivalis Therapeutics last raise money?
Nivalis Therapeutics's most recent round on record is a Series B, in Jul 2010.
What does Nivalis Therapeutics do?
Nivalis Therapeutics, headquartered in Boulder, US, was founded in 2007 to specialize in innovative therapies for cystic fibrosis.
Where is Nivalis Therapeutics headquartered?
Nivalis Therapeutics is headquartered in Boulder, US.
Which VCs invest in companies like Nivalis Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Nivalis Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Nivalis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.